Published 13 days ago • loading... • Updated 13 days agoShow Less IconGilead Sciences (NASDAQ:GILD) Downgraded by Leerink Partners to Market Perform Summary by MarketBeatLeerink Partners lowered shares of Gilead Sciences from an "outperform" rating to a "market perform" rating and set a $127.00 price target for the company. in a research report on Tuesday.Share menu1 Articles1 ArticlesAllLeftCenter1RightSearch IconSort IconMarketBeatCenterFactualityOwnershipGilead Sciences (NASDAQ:GILD) Downgraded by Leerink Partners to Market PerformLeerink Partners lowered shares of Gilead Sciences from an "outperform" rating to a "market perform" rating and set a $127.00 price target for the company. in a research report on Tuesday.13 days ago·Sioux Falls, United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right0Center1Last Updated13 days agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageMarketBeat broke the news in Sioux Falls, United States 13 days ago on Tuesday, July 21, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsFoster City Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsFoster City Plus IconShow All